Logo

Proteros

In Brief This Week: Illumina; Thermo Fisher Scientific; Accler8; Precision BioSciences, Cellectis; BG Medicine; More

NEW YORK (GenomeWeb News) – Illumina disclosed in its quarterly filing with the US Securities and exchange Commission that it paid a total consideration of $95.5 million for its acquisition of BlueGnome in July.

In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec

NEW YORK (GenomeWeb News) – Roche has selected the Alexandria Center for Life Science - New York City as the location for its Translational Clinical Research Center. The center will serve as the critical early development presence for Roche Pharma Research and Early Development in the US.

Proteros Providing X-ray Protein Structures to Nimbus for Drug Targets

Under a deal announced today, Proteros will provide structures from its Gallery Structure catalogue of ready-to-use proteins for X-ray structure analysis of protein-ligand complexes, as well as gene-to-structure projects for novel biological targets.

Proteros to Provide Discovery Services for Huntington's Foundation

The firm will provide the foundation with structure-based drug discovery services.

Proteros Inks Deal to Provide Access to UC DCC's Screening Platform

In the deal with the University of Cincinnati, Drug Discovery Center, Proteros will provide biotechnology and drug firms access to UC DCC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.